EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

ServiceUpdated on 9 September 2026

Brain-on-chip (BoC) platform for preclinical CNS pharmacology.

About

Take your modeling capabilities to the next level for your most demanding projects in CNS diseases!

  • In practice, our brain-on-chip-based models enable targeted investigation of your drug-candidate effects on synaptic plasticity, axonal growth or degeneration, and axonal transport mechanisms – including pathological spreading – across interconnected neuronal populations.

All ETAP-LAB’s brain‑on‑chip models are compatible with High‑Content Imaging technologies and are available SBS‑formatted plates (16 chips per plate) ensuring reproducibility and a throughput suitable to pharmaceutical industry standards.

Type

  • Development
  • Others

Applies to

  • Biotech and Lifescience
  • Medtech

Organisation

SYNCROSOME (ETAP SA)

Company (SME/startup) / 中小企業・スタートアップ

MARSEILLE, France